You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Claims for Patent: 8,372,827

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 8,372,827

Title:	Therapeutic compositions
Abstract:	Ingenol angelate is a potent anticancer agent, and can be stabilized by dissolving it in an aprotic solvent in the presence of an acidic buffer.
Inventor(s):	Brown; Marc Barry (Watford, GB), Crowthers; Michael Edward Donald (Hillsborough, GB), Nazir; Tahir (Isleworth, GB)
Assignee:	LEO Laboratories Limted (Dublin, IE)
Application Number:	13/563,716
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,372,827
Patent Claims:	1. A pharmaceutical formulation for topical use in treatment of a subject, said pharmaceutical formulation comprising ingenol angelate in an amount from about 0.001% to about 0.15% w/w, wherein at least about 97.5% of the ingenol angelate is ingenol-3-angelate (isoform `b`) and said pharmaceutical formulation has a pH of less than 4. 2. The pharmaceutical formulation of claim 1 having a pH of about 3.5 or less. 3. The pharmaceutical formulation of claim 1 having a pH of about 3.0. 4. The pharmaceutical formulation of claim 1 having a pH within the range of about 2.5 to less than 4.0. 5. The pharmaceutical formulation of claim 1, wherein said pharmaceutical formulation is a gel. 6. The pharmaceutical formulation of claim 1, wherein said pharmaceutical formulation is a cream. 7. The pharmaceutical formulation of claim 1, wherein said pharmaceutical formulation is an ointment. 8. The pharmaceutical formulation of claim 1, wherein said pharmaceutical formulation is a paint. 9. The pharmaceutical formulation of claim 1, wherein said pharmaceutical formulation is a lotion. 10. The pharmaceutical formulation of claim 1, wherein said pharmaceutical formulation is a foam. 11. The pharmaceutical formulation of claim 1, wherein said pharmaceutical formulation is a transdermal patch. 12. The pharmaceutical formulation of claim 1, wherein said pharmaceutical formulation is a sustained release formulation. 13. The pharmaceutical formulation of claim 1, wherein said pharmaceutical formulation is an emulsion. 14. The pharmaceutical formulation of claim 1, wherein said pharmaceutical formulation is an oil. 15. The pharmaceutical formulation of claim 1, wherein said pharmaceutical formulation is a buccal formulation. 16. The pharmaceutical formulation of claim 1, wherein said pharmaceutical formulation further comprises a penetration enhancer, a preservative, a gelling agent or a buffer.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.